Novo Nordisk Dips After Tightening Its Outlook As Wegovy Beats, But Ozempic Misses
Novo Nordisk stock inched down Wednesday after the drugmaker's weight-loss drug beat forecasts, but sales of its diabetes behemoth missed. The post Novo Nordisk Dips After Tightening Its Outlook As Wegovy Beats, But Ozempic Misses appeared first on Investor's Business Daily.
Novo Nordisk stock inched down Wednesday after the drugmaker's weight-loss drug beat forecasts, but sales of its diabetes behemoth missed.
The post Novo Nordisk Dips After Tightening Its Outlook As Wegovy Beats, But Ozempic Misses appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
